Mohs' micrographic surgery: History, principles, critical analysis of its efficacy and indications;Historique, principes, analyse critique de l'efficacité et indications de la chirurgie micrographique de Mohs

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 2, 2004, Pages 173-182

  Sei, J F ^a   Chaussade, V ^a   Zimmermann, U ^a   Tchakerian, A ^a   Clerici, T ^a   Franc, B ^a   Saiag, P ^a,b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOSURGERY; FOLLOW UP; FRANCE; HISTORY; HUMAN; REVIEW; SKIN TUMOR; TUMOR RECURRENCE;

EID: 1542720647     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(04)93566-1     Document Type: Review

References (47)

1. Mohs F. Chemosurgery: a microscopically contolled method of cancer excision. Arch Surg 1941;42:279-95.
2. Tromovitch TA, Stegeman SJ. Microscopically controlled excision of skin tumors. Arch Dermatol 1975;110:231-2.
3. Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW et al. Guidelines of care for Mohs micrographic surgery. American Academy of Dermatology. J Am Acad Dermatol 1995;33:271-8.
4. Mikhail GR. Mohs' micrographic surgery. Philadelphia: WB Sanders 1991.
5. Bailin PL, Ratz JL, Wheeland RG. Mohs Micrographic Surgery Technique. In: Saunders R, editor. Dermatologic Surgery.
6. Leffell DJ. An educational device for Mohs micrographic surgery. A three-dimensional model of basal cell carcinoma. J Dermatol Surg Oncol 1991;17:498-501.
7. Shriner DL, McCoy DK, Goldberg DJ, Wagner RF, Jr. Mohs micrographic surgery. J Am Acad Dermatol 1998;39:79-97.
8. Ackerman AB, Scheiner AM. How wide and deep is wide and deep enough? A critique of surgical practice in excisions of primary cutaneous malignant melanoma. Hum Pathol 1983;14:743-4.
9. Breuninger H, Castanet P. [Method of histological control of the edges of surgical specimens of basal cell epitheliomas]. Ann Dermatol Venereol 1987;114:511-4.
10. Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997;76:100-6.
11. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999;135:1177-83.
12. Rowe DE, Carroll RJ, Day CL, Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315-28.
13. Rowe DE, Carroll RJ, Day CL, Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424-31.
14. Rosin MP, Miller SJ, Schwab D, Westra WH, Sidransky D. Molecular analysis of effectiveness of Mohs' surgical technique. Lancet 1996;347:1692-3.
15. Grabski WJ, Salasche SJ, McCollough ML, Berkland ME, Gutierrez JA, Finstuen K. Interpretation of Mohs micrographic frozen sections: a peer review comparison study. J Am Acad Dermatol 1989;20:670-4.
16. Hruza GJ. Mohs micrographic surgery local recurrences. J Dermatol Surg Oncol 1994;20:573-7.
17. Sznadjer M, Chaussade V, Zimmermann U, Sei JF, Bendersky N, Franc B et al. Coût de la chirurgie micrographique de Mohs dans les carcinomes basocellulaires: L'expérience française. Ann Dermatol Venereol 2003 (in press).
18. Sei JF. Marges d'exérèse et reprises dans les carcinomes cutanés. Ann Dermatol Venereol 1997;124:421-6.
19. Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 2002;138:1043-51.
20. Randle HW. Basal cell carcinoma. Identification and treatment of the high-risk patient. Dermatol Surg 1996;22:255-61.
21. Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987;123:340-4.
22. Richmond JD, Davie RM. The significance of incomplete excision in patients with basal cell carcinoma. Br J Plast Surg 1987;40:63-7.
23. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990;23:1118-26.
24. Orengo IF, Salasche SJ, Fewkes J, Khan J, Thornby J, Rubin F. Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane. J Am Acad Dermatol 1997;37:395-7.
25. Hendrix JD, Jr, Parlette HL. Micronodular basal cell carcinoma. A deceptive histologic subtype with frequent clinically undetected tumor extension. Arch Dermatol 1996;132:295-8.
26. Welch ML, Anderson LL, Grabski WJ. How many nonmelanoma skin cancers require Mohs micrographic surgery? Dermatol Surg 1996;22:711-3.
27. Wennberg AM, Larko O, Stenquist B. Five-year results of Mohs' micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol 1999;79:370-2.
28. Rowe DE, Carroll RJ, Day CL, Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992;26:976-90.
29. Mohs F. Chemosurgery. In: Thomas CC, editor. Springfield (IL); 1978. p. 153-64.
30. Chiller K, Passaro D, Scheuller M, Singer M, McCalmont T, Grekin RC. Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome. Arch Dermatol 2000;136:1355-9.
31. Arnaud EJ, Perrault M, Revol M, Servant JM, Banzet P. Surgical treatment of dermatofibrosarcoma protuberans. Plast Reconstr Surg 1997;100:884-95.
32. Ratner D, Thomas CO, Johnson TM, Sondak VK, Hamilton TA, Nelson BR et al. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol 1997;37:600-13.
33. Parker TL, Zitelli JA. Surgical margins for excision of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1995;32:233-6.
34. Dawes KW, Hanke CW. Dermatofibrosarcoma protuberans treated with Mohs micrographic surgery: cure rates and surgical margins. Dermatol Surg 1996;22:530-4.
35. Gloster HM, Jr., Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996;35:82-7.
36. Massey RA, Tok J, Strippoli BA, Szabolcs MJ, Silvers DN, Eliezri YD. A comparison of frozen and paraffin sections in dermatofibrosarcoma protuberans. Dermatol Surg 1998;24:995-8.
37. Hafner J, Schutz K, Morgenthaler W, Steiger E, Meyer V, Burg G. Micrographic surgery ('slow Mohs') in cutaneous sarcomas. Dermatology 1999;198:37-43.
38. O'Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997;23:929-33.
39. Gollard R, Weber R, Kosty MP, Greenway HT, Massullo V, Humberson C. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer 2000;88:1842-51.
40. Zeitouni NC, Cheney RT, Delacure MD. Lymphoscintigraphy, sentinel lymph node biopsy, and Mohs micrographic surgery in the treatment of Merkel cell carcinoma. Dermatol Surg 2000;26:12-8.
41. Boyer JD, Zitelli JA, Brodland DG, D'Angelo G. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002;47:885-92.
42. Breuninger H, Schlagenhauff B, Stroebel W, Schaumburg-Lever G, Rassner G. Patterns of local horizontal spread of melanomas: consequences for surgery and histopathologic investigation. Am J Surg Pathol 1999;23:1493-8.
43. Barlow RJ, White CR, Swanson NA. Mohs' micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ. Br J Dermatol 2002;146:290-4.
44. Clayton BD, Leshin B, Hitchcock MG, Marks M, White WL. Utility of rush paraffin-embedded tangential sections in the management of cutaneous neoplasms. Dermatol Surg 2000;26:671-8.
45. Robinson JK. Margin control for lentigo maligna. J Am Acad Dermatol 1994;31:79-85.
46. Kelley LC, Starkus L. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. J Am Acad Dermatol 2002;46:78-84.
47. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997;37:236-45.